Ligong Chen

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

Nature communications

Cell discovery

Vaccines

Protein & cell

This page only lists publications with an associated author ORCID identifier.

Publications

Wenna Chi, Na Kang, Linlin Sheng, Sichen Liu, Lei Tao, Xizhi Cao, Ye Liu, Can Zhu, Yuming Zhang, Bolong Wu, Ruiqun Chen, Lili Cheng, Jing Wang, Xiaolin Sun, Xiaohui Liu, Haiteng Deng, Jinliang Yang, Zhanguo Li, Wanli Liu, Ligong Chen
MCT1-governed pyruvate metabolism is essential for antibody class-switch recombination through H3K27 acetylation. Nature communications 15 (1) (2024)
Wenna Chi, Na Kang, Linlin Sheng, Sichen Liu, Lei Tao, Xizhi Cao, Ye Liu, Can Zhu, Yuming Zhang, Bolong Wu, Ruiqun Chen, Lili Cheng, Jing Wang, Xiaolin Sun, Xiaohui Liu, Haiteng Deng, Jinliang Yang, Zhanguo Li, Wanli Liu, Ligong Chen
MCT1-governed pyruvate metabolism is essential for antibody class-switch recombination through H3K27 acetylation. Nature communications 15 (1) (2024)
Shuhao Zhang, Angqi Zhu, Fang Kong, Jianan Chen, Baoliang Lan, Guodong He, Kaixuan Gao, Lili Cheng, Xiaoou Sun, Chuangye Yan, Ligong Chen, Xiangyu Liu
Structural insights into human organic cation transporter 1 transport and inhibition. Cell discovery 10 (1) (2024)
Wenna Chi, Na Kang, Linlin Sheng, Sichen Liu, Lei Tao, Xizhi Cao, Ye Liu, Can Zhu, Yuming Zhang, Bolong Wu, Ruiqun Chen, Lili Cheng, Jing Wang, Xiaolin Sun, Xiaohui Liu, Haiteng Deng, Jinliang Yang, Zhanguo Li, Wanli Liu, Ligong Chen
MCT1-governed pyruvate metabolism is essential for antibody class-switch recombination through H3K27 acetylation. Nature communications 15 (1) (2024)
Shuhao Zhang, Angqi Zhu, Fang Kong, Jianan Chen, Baoliang Lan, Guodong He, Kaixuan Gao, Lili Cheng, Xiaoou Sun, Chuangye Yan, Ligong Chen, Xiangyu Liu
Structural insights into human organic cation transporter 1 transport and inhibition. Cell discovery 10 (1) (2024)
Hailong Qi, Zhongjie Sun, Yanling Yao, Ligong Chen, Xuncheng Su
Immunogenicity of the Xcl1 -SARS-CoV-2 Spike Fusion DNA Vaccine for COVID-19. Vaccines 10 (3) (2022)
Yiyue Ge, Tingzhong Tian, Suling Huang, Fangping Wan, Jingxin Li, Shuya Li, Xiaoting Wang, Hui Yang, Lixiang Hong, Nian Wu, Enming Yuan, Yunan Luo, Lili Cheng, Chengliang Hu, Yipin Lei, Hantao Shu, Xiaolong Feng, Ziyuan Jiang, Yunfu Wu, Ying Chi, Xiling Guo, Lunbiao Cui, Liang Xiao, Zeng Li, Chunhao Yang, Ze-Hong Miao, Ligong Chen, Haitao Li, Hainian Zeng, Dan Zhao, Fengcai Zhu, Xiaokun Shen, Jianyang Zeng
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19. Signal transduction and targeted therapy 6 (1) (2021)
Qingjun Liu, Zhongjie Sun, Ligong Chen
Memory T cells: strategies for optimizing tumor immunotherapy. Protein & cell 11 (8) (2020)
Wenxin Song, Qi Luo, Yuping Zhang, Linkang Zhou, Ye Liu, Zhilong Ma, Jianan Guo, Yuedong Huang, Lili Cheng, Ziyi Meng, Zicheng Li, Bin Zhang, Siqi Li, Sook Wah Yee, Hao Fan, Peng Li, Kathleen M Giacomini, Ligong Chen
Organic cation transporter 3 (Oct3) is a distinct catecholamines clearance route in adipocytes mediating the beiging of white adipose tissue. PLoS biology 17 (1) (2019)

Ligong Chen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ligong Chen